HUP0401485A3 - Pharmaceutical composition containing combination of selected opioids with muscarine antagonists for treating urinary incontinence - Google Patents
Pharmaceutical composition containing combination of selected opioids with muscarine antagonists for treating urinary incontinenceInfo
- Publication number
- HUP0401485A3 HUP0401485A3 HU0401485A HUP0401485A HUP0401485A3 HU P0401485 A3 HUP0401485 A3 HU P0401485A3 HU 0401485 A HU0401485 A HU 0401485A HU P0401485 A HUP0401485 A HU P0401485A HU P0401485 A3 HUP0401485 A3 HU P0401485A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical composition
- composition containing
- urinary incontinence
- treating urinary
- containing combination
- Prior art date
Links
- UQOFGTXDASPNLL-XHNCKOQMSA-N Muscarine Chemical compound C[C@@H]1O[C@H](C[N+](C)(C)C)C[C@H]1O UQOFGTXDASPNLL-XHNCKOQMSA-N 0.000 title 1
- 206010046543 Urinary incontinence Diseases 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 229940005483 opioid analgesics Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10146275A DE10146275A1 (de) | 2001-09-18 | 2001-09-18 | Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz |
| PCT/EP2002/010460 WO2003024444A1 (de) | 2001-09-18 | 2002-09-18 | Kombination ausgewählter opioide mit muscarin-antagonisten zur therapie der harninkontinenz |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0401485A2 HUP0401485A2 (hu) | 2004-11-29 |
| HUP0401485A3 true HUP0401485A3 (en) | 2008-04-28 |
Family
ID=7699618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0401485A HUP0401485A3 (en) | 2001-09-18 | 2002-09-18 | Pharmaceutical composition containing combination of selected opioids with muscarine antagonists for treating urinary incontinence |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20040242617A1 (hu) |
| EP (1) | EP1429754B1 (hu) |
| JP (1) | JP4511176B2 (hu) |
| KR (1) | KR100891438B1 (hu) |
| CN (1) | CN100384413C (hu) |
| AT (1) | ATE383854T1 (hu) |
| AU (1) | AU2002342707B2 (hu) |
| BR (1) | BR0212714A (hu) |
| CA (1) | CA2460655C (hu) |
| DE (2) | DE10146275A1 (hu) |
| EC (1) | ECSP045025A (hu) |
| ES (1) | ES2299608T3 (hu) |
| HK (1) | HK1075205A1 (hu) |
| HU (1) | HUP0401485A3 (hu) |
| IL (2) | IL160894A0 (hu) |
| MX (1) | MXPA04002510A (hu) |
| NO (1) | NO333016B1 (hu) |
| NZ (1) | NZ531777A (hu) |
| PL (1) | PL209272B1 (hu) |
| RU (1) | RU2305562C2 (hu) |
| WO (1) | WO2003024444A1 (hu) |
| ZA (1) | ZA200402853B (hu) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10146275A1 (de) | 2001-09-18 | 2003-04-24 | Gruenenthal Gmbh | Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz |
| US7410965B2 (en) | 2002-05-29 | 2008-08-12 | Gruenenthal Gmbh | Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-ol |
| DE10224108A1 (de) * | 2002-05-29 | 2004-01-29 | Grünenthal GmbH | 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung |
| DE10224556A1 (de) * | 2002-05-31 | 2004-01-08 | Grünenthal GmbH | 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen |
| JP2006511624A (ja) * | 2002-12-20 | 2006-04-06 | ダイノジェン ファーマシューティカルズ， インコーポレイテッド | α２δサブユニット・カルシウム・チャンネル調節因子を使用する無痛性膀胱障害を処置するための方法 |
| JP2006520799A (ja) * | 2003-03-21 | 2006-09-14 | ダイノジェン ファーマシューティカルズ， インコーポレイテッド | 平滑筋調節因子およびα２δサブユニットカルシウムチャネル調節因子を用いた、下部尿路障害を処置するための方法 |
| DE10356362A1 (de) * | 2003-11-28 | 2005-06-23 | Grünenthal GmbH | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen |
| WO2005113486A1 (en) * | 2004-05-14 | 2005-12-01 | Janssen Pharmaceutica N.V. | Carboxamido opioid compounds |
| DE102005009217A1 (de) * | 2005-02-25 | 2006-08-31 | Grünenthal GmbH | Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen |
| WO2007009794A1 (de) * | 2005-07-22 | 2007-01-25 | Grünenthal GmbH | Hcl-polymorphe von 3 - ( 2- (dimethylamino) methyl- ( cyclohex-i-yl) ) phenol |
| US20070032551A1 (en) * | 2005-07-22 | 2007-02-08 | Gruenenthal Gmbh | Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof |
| US7884247B2 (en) * | 2005-07-22 | 2011-02-08 | Gruenenthal Gmbh | Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof |
| DE102007022790A1 (de) * | 2007-05-11 | 2008-11-20 | Grünenthal GmbH | Axomadol zur Schmerzbehandlung bei Arthrose |
| CN102281876A (zh) * | 2008-10-30 | 2011-12-14 | 格吕伦塔尔有限公司 | 新型有效的他喷他多剂型 |
| WO2011110595A1 (de) | 2010-03-10 | 2011-09-15 | Grünenthal GmbH | Kristalline salze und/oder cokristalle von o-desmethyltramadol |
| CN102946870A (zh) | 2010-05-10 | 2013-02-27 | 欧洲凯尔特公司 | 包含氢吗啡酮和纳洛酮的药物组合物 |
| EP2568968B1 (en) | 2010-05-10 | 2017-07-12 | Euro-Celtique S.A. | Manufacturing of active-free granules and tablets comprising the same |
| US9901540B2 (en) | 2010-05-10 | 2018-02-27 | Euro-Celtique S.A. | Combination of active loaded granules with additional actives |
| CN103040828B (zh) * | 2013-01-07 | 2015-12-02 | 常州康普药业有限公司 | 复方地芬诺酯片及其制备方法 |
| WO2015071380A1 (en) | 2013-11-13 | 2015-05-21 | Euro-Celtique S.A. | Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB857194A (en) * | 1957-07-05 | 1960-12-29 | Clinical Products Ltd | Therapeutic agents comprising ion-exchange resins |
| NL127065C (hu) | 1964-04-22 | |||
| US5736577A (en) | 1995-01-31 | 1998-04-07 | Sepracor, Inc. | Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin |
| DE3012837A1 (de) * | 1979-04-10 | 1980-10-30 | Sandoz Ag | Analgetische und myotonolytische praeparate |
| DE3129982A1 (de) * | 1981-07-29 | 1983-02-17 | Jutta 8200 Rosenheim Meyer | "antiallergikum" |
| US5073560A (en) | 1990-07-20 | 1991-12-17 | Fisons Corporation | Spiro-isoxazolidine derivatives as cholinergic agents |
| DE4041559A1 (de) | 1990-12-22 | 1992-06-25 | Boehringer Ingelheim Kg | Neue wirkstoffkombinationen |
| DE4426245A1 (de) * | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| WO1996027375A2 (en) * | 1995-03-03 | 1996-09-12 | Algos Pharmaceutical Corporation | Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence |
| DE19525137C2 (de) | 1995-07-11 | 2003-02-27 | Gruenenthal Gmbh | 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe |
| DE19609847A1 (de) * | 1996-03-13 | 1997-09-18 | Gruenenthal Gmbh | Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe |
| EP0924983A4 (en) | 1996-07-19 | 1999-08-25 | Gunnar Aberg | S (-) - TOLTERODINE FOR THE TREATMENT OF URINARY AND GASTROINTESTINAL DISORDERS |
| DE69830728T2 (de) * | 1997-04-11 | 2006-05-18 | Nippon Shinyaku Co., Ltd. | Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz |
| PE20010623A1 (es) * | 1999-10-05 | 2001-07-07 | Gruenenthal Chemie | Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria |
| JP2003523382A (ja) * | 2000-02-24 | 2003-08-05 | ファルマシア・アンド・アップジョン・カンパニー | 新規な薬物の組合せ |
| DE10059412A1 (de) * | 2000-11-30 | 2002-06-13 | Gruenenthal Gmbh | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz |
| DE10146275A1 (de) | 2001-09-18 | 2003-04-24 | Gruenenthal Gmbh | Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz |
-
2001
- 2001-09-18 DE DE10146275A patent/DE10146275A1/de not_active Withdrawn
-
2002
- 2002-09-18 CN CNB028227794A patent/CN100384413C/zh not_active Expired - Fee Related
- 2002-09-18 RU RU2004111788/15A patent/RU2305562C2/ru not_active IP Right Cessation
- 2002-09-18 MX MXPA04002510A patent/MXPA04002510A/es active IP Right Grant
- 2002-09-18 KR KR1020047004002A patent/KR100891438B1/ko not_active IP Right Cessation
- 2002-09-18 WO PCT/EP2002/010460 patent/WO2003024444A1/de active IP Right Grant
- 2002-09-18 CA CA2460655A patent/CA2460655C/en not_active Expired - Fee Related
- 2002-09-18 JP JP2003528540A patent/JP4511176B2/ja not_active Expired - Fee Related
- 2002-09-18 AT AT02779368T patent/ATE383854T1/de active
- 2002-09-18 PL PL369235A patent/PL209272B1/pl unknown
- 2002-09-18 BR BR0212714-8A patent/BR0212714A/pt not_active Application Discontinuation
- 2002-09-18 ES ES02779368T patent/ES2299608T3/es not_active Expired - Lifetime
- 2002-09-18 DE DE50211566T patent/DE50211566D1/de not_active Expired - Lifetime
- 2002-09-18 EP EP02779368A patent/EP1429754B1/de not_active Expired - Lifetime
- 2002-09-18 AU AU2002342707A patent/AU2002342707B2/en not_active Ceased
- 2002-09-18 IL IL16089402A patent/IL160894A0/xx unknown
- 2002-09-18 NZ NZ531777A patent/NZ531777A/en not_active IP Right Cessation
- 2002-09-18 HU HU0401485A patent/HUP0401485A3/hu unknown
-
2004
- 2004-03-12 NO NO20041059A patent/NO333016B1/no not_active IP Right Cessation
- 2004-03-16 IL IL160894A patent/IL160894A/en not_active IP Right Cessation
- 2004-03-17 EC EC2004005025A patent/ECSP045025A/es unknown
- 2004-03-18 US US10/803,187 patent/US20040242617A1/en not_active Abandoned
- 2004-04-15 ZA ZA2004/02853A patent/ZA200402853B/en unknown
-
2005
- 2005-08-29 HK HK05107560.0A patent/HK1075205A1/xx not_active IP Right Cessation
-
2011
- 2011-09-23 US US13/242,672 patent/US8946290B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0401485A3 (en) | Pharmaceutical composition containing combination of selected opioids with muscarine antagonists for treating urinary incontinence | |
| AU2002342707A1 (en) | Combination of selected opioids with muscarine antagonists for treating urinary incontinence | |
| HK1067362A1 (en) | Heterocyclic compounds for use in the treatment ofdisorders of the urinary tract | |
| ZA200305691B (en) | The use of substituted azetidione compounds for the treatment of sitosterolemia | |
| HUP0401656A3 (en) | Mch antagonists for the treatment of obesity and pharmaceutical compositions containing them | |
| AU2001286557A1 (en) | Method of treating or preventing urinary incontinence using prostanoid ep1 receptor antagonists | |
| HUP0400349A3 (en) | Ccr5 antagonists useful for treating aids and pharmaceutical compositions containing them | |
| IL158050A0 (en) | Use of selective cox-2 inhibitors for the treatment of urinary incontinence | |
| HUP0401612A3 (en) | Pharmaceutical composition suitable for treating diabetes | |
| HUP0302430A3 (en) | Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontience | |
| HUP0300860A3 (en) | Pharmaceutical compositions suitable for treatment of urinary dysfunction | |
| HUP0500162A2 (en) | Heterocyclic compounds useful for preventives/remedies for urinary disturbance and pharmaceutical compounds thereof | |
| HUP0200288A3 (en) | Use of pde4 for treating copd | |
| AU2002233210A1 (en) | Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence | |
| HK1103010A1 (en) | Composition for prevention and treatment of urinary incontinence | |
| AU2001247947A1 (en) | Composition for treating steel making slags | |
| HUP0303285A3 (en) | Use of weak opioids and mixed opioid agonists/antagonists for preparing of pharmaceutical composition for treating urinary incontinence | |
| AU2002220736A1 (en) | Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence | |
| HUP0303268A3 (en) | Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence | |
| HUP0303046A3 (en) | Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence and pharmaceutical compositions containing them | |
| AU2002223688A1 (en) | Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence | |
| AU2002233209A1 (en) | Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence | |
| HUP0302984A3 (en) | Utilization of buprenorphine for preparation of pharmaceutical composition useful in urinary incontinence therapy | |
| HK1046848A1 (en) | Specific therapeutic composition for treating aids | |
| AU2003283153A8 (en) | Pharmaceutical compositions for the treatment of urinary incontinence |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |